Course on Lung cancer and mesothelioma
June, 17- 18.
The incidence of lung cancer and mesothelioma is still increasing in Central Eastern Europe, especially in younger ages and in women. With new treatment modalities patients are living longer but there is still a lack of proper palliative care measurements in many societies. In addition, methods of early detection, even though still very scarce, need to be improved.
PAYMENT
Registration fee is € 100 for specialists and € 50 for residents. Registration and payment must be processed by 30 April 2010. No on site registrations will be accepted. The registration fee covers admission to the course, a copy of the programme, coffee breaks, lunches and dinners throughout the course as indicated in the programme, daily transfers from/to the boarding point of hotel.
BANK TRANSFER with no cost to the beneficiary addressed to: University Clinic of Respiratory and Allergic Diseases Golnik, Golnik 36, Slovenia
Bank: Banka Slovenije, Slovenska cesta 35, 1505 Ljubljana, Slovenia
SWIFT code: BSLJSI2X
Account holder: University Clinic of Respiratory and Allergic Diseases Golnik, Slovenia
Number: 01100 – 6030277603
IBAN: SI56011006030277603
Reference: “ESO 2010” + your name
ACCOMMODATION
Participants who need hotel accommodation can contact Kokra Hotel in Brdo pri Kranju and book directly at the hotel. Special rates have been negotiated with the hotel, therefore the participants should mention that he/she will attend the ESO Slovenia course on 17-18 June.
Single bedroom with breakfast: 106 EUR (per person)
Double bedroom with breakfast: 85 EUR (per person)
CONTACT
Irena Dolhar
Klinika Golnik, Golnik 36, 4204 Golnik
Slovenija/Slovenia
Tel: + 386 4 25 69 493
Fax: + 386 4 25 69 117
Program
Thursday, 17 June
| 8:15 | Welcome address T. Cufer, SI |
| 8:30 | Lung cancer and mesothelioma epidemiology M. Primic Zakelj, SI |
| 9:00 | Role of invasive procedures in diagnostic and staging of lung cancer N. Triller, SI |
| 9:30 | Role of invasive procedures in diagnostic and staging of mesotelioma N. Schoenfeld, DE |
| 10:00 | Role of PET-CT and molecular imaging staging in therapy planning I. Zagar, SI |
| 10:30 | Pathology and molecular biology of lung cancer and mesothelioma I. Kern, SI |
| 11:00 | Coffee break |
| 11:30 | Lung cancer and mesothelioma surgery P. Van Schil, BE |
| 12:00 | Systemic therapy and radiotherapy in mesothelioma G.L. Ceresoli, IT |
| 12:30 | Radiotherapy in lung cancer E. Vrdoljak, HR |
| 13:00 | Systemic therapies for lung cancer P. Postmus, NL |
| 13:30 | Lunch break |
| 14:30 | Interactive clinical cases (presented by participants and discussed by experts) Discussants: N. Triller, I. Kern, P. Van Schil, G. L. Ceresoli, E. Vrdoljak, P. Postmus Moderator: T. Cufer 14:30 NSCLC stage IIIA and stage IV |
Program
Friday, 18 June
| 9:00 | Supportive and symptomatic care of patients on systemic therapies T. Cufer, SI |
| 9:30 | Supportive and symptomatic care of patients on radiotherapy V. Kovac, SI |
| 10:00 | Palliation of malignant pleural effusion A. Rozman, SI |
| 10:30 | Principles of palliative care and end of life measurements U. Lunder, SI |
| 11:00 | Coffee break |
| 11:30 | How to improve early detection of lung cancer and mesothelioma G.L. Ceresoli, IT |
| 12:00 | Combined chemo-radiotherapy in lung cancer, reality or a dream M. Zwitter, SI |
| 12:30 | Is individualized therapy for lung cancer viable today V. Gregorc, IT |
| 13:00 | Lunch break |
| 14:00 | Non-invasive surgical procedures in lung cancer J. Erzen, SI |
| 14:30 | How to ensure palliation of symptoms and end of life measurements at home U. Lunder, SI |
| 15:00 | Round table discussion How to improve lung cancer control in 21st century ? Panelists: G.L. Ceresoli, T. Cufer, V. Gregorc, U. Lunder, N.M. Zwitter |
| 16:00 | Adjourn |
